VIAV Stock Analysis: Viavi Solutions | NASDAQ
Communication Equipment | NASDAQ, USA | Market Cap: 11.839m USD | 12M Return: 259.1% | US9255501051 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 221M
EPS Trend: 81.6%
Qual. Beats: 7
Rev. Trend: 83.7%
Qual. Beats: 5
Warnings
Tailwinds
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Viavi Solutions Inc. (NASDAQ: VIAV) is a U.S.-based communications equipment provider headquartered in Chandler, Arizona, that delivers test and measurement and optical technologies to military, aerospace, railway, and first-responder communications markets across the Americas, EMEA, and Asia-Pacific. Founded in 1923 and formerly known as JDS Uniphase Corporation, the company has been public since 1993 and carries a large-cap market capitalization of roughly $10.1 billion. Its diversified revenue base spans two operating segments: Network and Service Enablement (NSE), which offers test, monitoring, assurance, and resilient positioning, navigation, and timing (PNT) solutions for critical infrastructure, along with instruments, software, and lifecycle services; and Optical Security and Performance Products (OSP), which applies proprietary optical coating and high-volume manufacturing capabilities to anti-counterfeiting, 3D sensing, government/aerospace, automotive, and industrial end markets. The dual-segment model blends recurring service and software support revenue with component-level optical sales, positioning Viavi across both telecom infrastructure workflows and broader industrial sensing applications.
- 5G and fiber capex cycle drives NSE test equipment demand
- 3D sensing revenue from consumer electronics anchors OSP segment
- Defense and aerospace optical orders offset telecom cyclicality
| Net Income: -30.4m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA -0.05 > 1.0 |
| NWC/Revenue: 37.94% < 20% (prev 27.25%; Δ 10.68% < -1%) |
| CFO/TA 0.04 > 3% & CFO 113.9m > Net Income -30.4m |
| Net Debt (105.4m) to EBITDA (158.6m): 0.66 < 3 |
| Current Ratio: 1.85 > 1.5 & < 3 |
| Outstanding Shares: last quarter (229.5m) vs 12m ago 1.10% < -2% |
| Gross Margin: 57.66% > 18% (prev 56.84%; Δ 0.82% > 0.5%) |
| Asset Turnover: 64.62% > 50% (prev 54.38%; Δ 10.23% > 0%) |
| Interest Coverage Ratio: 1.28 > 6 (EBIT TTM 60.6m / Interest Expense TTM 47.4m) |
| A: 0.21 (Total Current Assets 1.26b - Total Current Liabilities 680.5m) / Total Assets 2.71b |
| B: -25.76 (Retained Earnings -69.7b / Total Assets 2.71b) |
| C: 0.03 (EBIT TTM 60.6m / Avg Total Assets 2.35b) |
| D: 1.15 (Book Value of Equity 1.45b / Total Liabilities 1.26b) |
| Altman-Z'' = -81.19 = D |
| DSRI: 0.86 (Receivables 351.3m/293.2m, Revenue 1.52b/1.08b) |
| GMI: 0.99 (GM 56.84% / 57.66%) |
| AQI: 1.07 (AQ_t 0.45 / AQ_t-1 0.42) |
| SGI: 1.40 (Revenue 1.52b / 1.08b) |
| TATA: -0.05 (NI -30.4m - CFO 113.9m) / TA 2.71b) |
| Beneish M = -2.83 (Cap -4..+1) = A |
As of October 10, 2026, the stock is trading at USD 45.46 with a total of 2,778,948 shares traded. Over the past week, the price has changed by -3.48%, over one month by +16.03%, over three months by +6.02% and over the past year by +259.08%.
Current recommended Stop Loss: 42.40 (which is 6.7% or 1.2 ATR below the current price).
Viavi Solutions has received a consensus analysts rating of 4.63. Therefore, it is recommended to buy VIAV.
- StrongBuy: 6
- Buy: 1
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 61.4 | 35.1% |
P/E Forward = 22.0751
P/S = 7.7973
P/B = 6.2058
P/EG = 1.3402
Revenue TTM = 1.52b USD
EBIT TTM = 60.6m USD
EBITDA TTM = 158.6m USD
Long Term Debt = 397.1m USD (from longTermDebt, last quarter)
Short Term Debt = 257.1m USD (from shortTermDebt, last quarter)
Debt = 755.2m USD (from shortLongTermDebtTotal, last quarter) + Leases 56.4m
Net Debt = 105.4m USD (calculated: Debt 755.2m - CCE 649.8m)
Enterprise Value = 11.9b USD (11.8b + Debt 755.2m - CCE 649.8m)
Interest Coverage Ratio = 1.28 (Ebit TTM 60.6m / Interest Expense TTM 47.4m)
EV/FCF = 144.3x (Enterprise Value 11.9b / FCF TTM 82.8m)
FCF Yield = 0.69% (FCF TTM 82.8m / Enterprise Value 11.9b)
FCF Margin = 5.45% (FCF TTM 82.8m / Revenue TTM 1.52b)
Net Margin = -2.00% (Net Income TTM -30.4m / Revenue TTM 1.52b)
Gross Margin = 57.66% ((Revenue TTM 1.52b - Cost of Revenue TTM 642.9m) / Revenue TTM)
Gross Margin QoQ = 62.49% (prev 55.73%)
Tobins Q-Ratio = 4.41 (Enterprise Value 11.9b / Total Assets 2.71b)
Interest Expense / Debt = 6.28% (Interest Expense 47.4m / Debt 755.2m)
Taxrate = 25.85% (11.4m / 44.1m)
NOPAT = 44.9m (EBIT 60.6m * (1 - 25.85%))
Current Ratio = 1.85 (Total Current Assets 1.26b / Total Current Liabilities 680.5m)
Debt / Equity = 0.52 (Debt 755.2m / totalStockholderEquity, last quarter 1.45b)
Debt / EBITDA = 0.66 (Net Debt 105.4m / EBITDA 158.6m)
Debt / FCF = 1.27 (Net Debt 105.4m / FCF TTM 82.8m)
Total Stockholder Equity = 963.3m (last 4 quarters mean from totalStockholderEquity)
RoA = -1.29% (Net Income -30.4m / Total Assets 2.71b)
RoE = -3.16% (Net Income TTM -30.4m / Total Stockholder Equity 963.3m)
RoCE = 4.45% (EBIT 60.6m / Capital Employed (Equity 963.3m + L.T.Debt 397.1m))
RoIC = 2.04% (NOPAT 44.9m / Invested Capital 2.21b)
WACC = 12.50% (E(11.8b)/V(12.6b) * Re(13.0%) + D(755.2m)/V(12.6b) * Rd(6.28%) * (1-Tc(0.26)))
Discount Rate = 13.0% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 55.82 | Cagr: 1.29%
[DCF] Terminal Value 65.76% ; FCFF base≈74.5m ; Y1≈85.4m ; Y5≈125.7m
[DCF] Fair Price = 3.99 (EV 1.09b - Net Debt 105.4m = Equity 981.6m / Shares 245.9m; r=12.50% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 81.63 | EPS CAGR: 36.65% | SUE: 3.07 | # QB: 7
Revenue Correlation: 83.67 | Revenue CAGR: 13.78% | SUE: 2.09 | # QB: 5
EPS current Quarter (2026-09-30): EPS=0.41 | Chg30d=-0.10% | Revisions=+67% | Analysts=6
EPS next Quarter (2026-12-31): EPS=0.40 | Chg30d=-1.09% | Revisions=+67% | Analysts=6
EPS current Year (2027-06-30): EPS=1.64 | Chg30d=-0.07% | Revisions=-25% | GrowthEPS=+64.2% | GrowthRev=+24.6%
EPS next Year (2028-06-30): EPS=1.95 | Chg30d=+0.00% | Revisions=+17% | GrowthEPS=+18.8% | GrowthRev=+13.2%
[Analyst] Revisions Ratio: +63% (up=14, down=2)